
Big Pharma is cost driver of GAVI
MSF demanded the GAVI to immediately stop paying out funds from a remaining US$262m subsidy to Pfizer and GlaxoSmithKline (GSK) for the pneumococcal...

2nd ECP Summer Summit at Henkel HQ, Düsseldorf
On September 26, international representatives from startups, SMEs, large companies. clusters, industry parks and further services providers came...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

BioVersys receives up to €8m from CARB-X
Privately-owned BioVersys AG, headquartered in Basel, is focusing on research and development of small molecules for multidrug-resistant bacterial...

Patient's organoids predict response to chemotherapy
The organoid-based test, developed by the group of Emile Voest at Netherland’s Cancer Institute in Amsterdam, in a prospective clinical trial...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...